Anya Hammann‐Haenni

Author

Anya Hammann‐Haenni

Also Known As

A. Hammann‐Haenni, Anya Hammann-Haenni, Anya Hammann‐Haenni

Publications

639

Citations

H-Index

Concepts

All Affiliations

Anya Hammann‐Haenni is an author at Ludwig Cancer Research specializing in immunology, medicine, and immunotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	240
2	Immunology	2	2	240
3	Allergy	1	1	163
4	Allergy Medicine	1	1	163
5	Cell Biology	1	1	77

Anya Hammann‐Haenni

Publications

639

Citations

H-Index

Page 1

	Year	Citations
Nano‐particle vaccination combined with <scp>TLR</scp>‐7 and ‐9 ligands triggers memory and effector <scp>CD</scp>8<sup>+</sup><scp>T</scp>‐cell responses in melanoma patients Simone M. Goldinger, Reinhard Dummer, Petra Baumgaertner, European Journal of Immunology	2012	191
The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma Kai-Michael Beeh, Frank Kanniess, Frank Wagner, Journal of Allergy and Clinical Immunology AsthmaAllergyAllergy MedicineMedicineImmunology	2013	163
Assessment of clinical efficacy of CYT003‐QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study Ludger Klimek, Jörg Willers, Anya Hammann‐Haenni, Clinical & Experimental Allergy	2011	141
Virus‐like particles induce robust human T‐helper cell responses Marion Braun, Camilla Jandus, Patrik Maurer, European Journal of Immunology Adaptive Immune SystemHumoral ResponseImmunologyImmune RegulationImmunodominance	2011	77
<scp>CYT</scp>003, a <scp>TLR</scp>9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study Thomas B. Casale, Jeremy Cole, Ekkehard Beck, Allergy	2015	67

Page 1